Suppr超能文献

商讨妊娠滋养细胞肿瘤的分期及风险因素评分系统。进展报告。

Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report.

作者信息

Kohorn Ernest I

机构信息

Department of Gynecology and Obstetrics, Yale University School of Medicine, New Haven, Connecticut, USA.

出版信息

J Reprod Med. 2002 Jun;47(6):445-50.

Abstract

OBJECTIVE

To discuss the current problems in establishing a unified staging and risk factor scoring system for trophoblastic disease under the auspices of the International Federation of Gynecology and Obstetrics (FIGO).

STUDY DESIGN

To present a history of the classifications of trophoblastic disease and compare these with the proposals presented to FIGO by the International Society for the Study of Trophoblastic Disease, the International Gynecologic Cancer Society and the Society of Gynecologic Oncologists.

RESULTS

The situation concerning the proposed 2000 FIGO trophoblast classification was resolved by FIGO's acceptance of the recommendations outlined in this paper.

CONCLUSION

There is a scientific and clinical need for FIGO to adopt the recommendations of the majority of physicians with expertise in treating trophoblastic disease for a rational classification of trophoblastic disease. It is gratifying that FIGO has done so.

摘要

目的

探讨在国际妇产科联盟(FIGO)主持下建立统一的滋养细胞疾病分期及危险因素评分系统过程中目前存在的问题。

研究设计

介绍滋养细胞疾病分类的历史,并将其与国际滋养细胞疾病研究学会、国际妇科癌症学会和妇科肿瘤学家学会提交给FIGO的提议进行比较。

结果

FIGO接受了本文概述的建议,从而解决了关于2000年FIGO滋养细胞分类提议的相关情况。

结论

FIGO有科学和临床需求采用大多数治疗滋养细胞疾病的专家的建议,以便对滋养细胞疾病进行合理分类。令人欣慰的是,FIGO已经这样做了。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验